Why is Anuh Pharma falling/rising?

As of 24-Sep, Anuh Pharma Ltd is experiencing a decline in its stock price, currently at 85.00, reflecting a decrease of 1.29 or 1.49%. The stock has underperformed its sector today by 1.04% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 36.38% compared to the 5-day average. Over the past year, the stock has generated a return of -16.67%, which is notably worse than the broader market's decline of -3.77%. The company's profits have also decreased by 20.2%, contributing to a negative sentiment around its performance.
Broader Market Context: In the short term, Anuh Pharma's performance has been weaker than the benchmark, with a 1-week return of -3.40% compared to the Sensex's -1.18%. This underperformance is indicative of broader challenges faced by the company, including poor long-term growth prospects, as evidenced by a low operating profit growth rate of 12.37% over the last five years. Furthermore, the company's recent negative financial results, including a significant drop in profit after tax and the lowest dividend per share, have compounded the negative outlook, leading to a perception of the stock as a strong sell.